Lisa O’Neill advises companies on a wide range of corporate and energy transactions, including mergers, acquisitions and divestitures, takeovers, joint ventures, re-organisations and commercial contracts. Lisa’s clients include major international and independent oil and gas companies, mining groups, corporates, infrastructure funds, financial institutions and private equity funds.
Represented Praxair, Inc. in the $3.3 billion divestment of North American and South American assets by Praxair, Inc. and Linde AG to Messer and CVC Capital Partners Fund VII. The divestments were subject to regulatory approvals and required for the consummation of the US$90 billion Praxair-Linde merger
Advised on the €5 billion (US$5.85 billion) divestment of the majority of Praxair’s businesses in Europe to Taiyo Nippon Sanso Corporation, a company listed on the Tokyo Stock Exchange and majority owned by Mitsubishi Chemical Holdings Corporation
Advised Centricus on establishing a multi-billion alternative investment platform
Advised Actuant, a NYSE listed diversified industrial company, on a series of disposals of oil field services companies and asset swaps
Advised Praxair, Inc on the acquisition of Yara’s European CO2 business for €300 million
Advised RWE Dea as the target in the sale by its parent company, RWE AG, for €5.1 billion, and, separately, in a joint venture with BP on a US$10 billion development agreement with the Egyptian government
Advised Centricus on its arrangement with SoftBank in connection with the establishment of the US$100 billion Vision Fund
Advised the Al-Thani family on the acquisition of Claridges, the Connaught and the Berkeley hotels
Advised Shell on the sale of its liquefied petroleum gas (LPG) businesses in eight European countries
Advised Vale SA on the USD$4.9 billion sale of bauxite, alumina and aluminum mining and smelting assets to Norsk Hydro ASA
Advised RWE AG on its £11 billion bid for British Energy
Advised Praxair Gases UK Limited on its acquisition of UK-based medical devices manufacturer NOxBOX Ltd, a manufacturer and vendor of instruments for use in inhaled nitric oxide therapy worldwide
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.